Is ECG stock a Buy, Sell, or Hold?

Based on our analysis, ECG is currently a HOLD with low confidence. 📊 HOLD: ECG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of ECG stock?

Our analysis estimates the fair value range for ECG to be between $139.63 and $159.48. The current price is $133.32.

What is the analyst price target for ECG?

The average Wall Street analyst price target for ECG is $169.60. This implies a potential upside of 27.2% from current levels.

ECG Stock Analysis: Buy, Sell, or Hold?

ECG - Everus Construction Group, Inc.

OPERATIVE BUILDERS

$133.32

-3.36 (-2.46%) ▼

5d: -7.33%

30d: -2.49%

90d: +2.3%

HOLD

LOW Confidence

Protect Your ECG Gains

Analysis Updated: Jul 13, 2026 12:00 AM ET

Earnings: Aug 11, 2026 27d

Get Alerted When ECG Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: ECG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 10.9%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$183.10

Based on 7.4% avg growth

INTRINSIC VALUE TODAY

$113.69

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: ECG is currently trading at $133.32, which is considered oversold relative to its 30-day fair value range of $139.63 to $159.48. The stock's valuation (Forward PE: 26.0) is in line with its historical norms (26.6). Remarkably, the market is currently pricing in an annual earnings decline of 0.7% over the next few years. This pessimistic expectation contrasts with the company's recent 58.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, ECG is in a strong uptrend. The price is currently testing key support at $139.94. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: ECG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $169.60 (+27.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $139.63 - $159.48

Company Quality Score 48/100 (HOLD)

Options IV Signal 25th percentile (COMPLACENCY WARNING)

Volume Confirmation HIGH

Confidence Score 65.4%

Protect Your Profits

Holding ECG? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BULLISH: Options cheap (IV 25th percentile)
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 27.2% below Wall St target ($169.60)
CAUTION: Recommendation downgraded due to -7.3% 5-day decline

Trading Range Analysis

30-Day Trading Range $139.63 - $159.48

Current vs Trading Range OVERSOLD

Expected Move (7 Days) ±$13.23 (9.9%)

Support & Resistance Levels

Support Level $139.94

Resistance Level $159.50

Current Trend Strong Uptrend

Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) 26.04

Wall Street Target $169.60 (+27.2%)

Revenue Growth (YoY) 25.4%

Earnings Growth (YoY) 58.7%

Profit Margin 5.7%

Valuation Discount vs History -0.7% cheaper

PE vs Historical 26.0 vs 26.6 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -0.7% (market-implied from PE analysis)

1-Year Target $132.39 (-1%)

2-Year Target $131.46 (-1%)

3-Year Target $130.54 (-2%)

3-Yr Target (if PE normalizes) (PE: 26→27) $133.35 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 26.0, Growth: 10.9%) $181.66 (+36%)

Base: (SPY PE: 21.8, Growth: 10.9%) $151.95 (+14%)

Bear: (PE: 18.5, Growth: 10.9%) $129.15 (-3%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (26x PE) as earnings recover.

Trailing PE: 31.28 | Current EPS (TTM): $4.37

Bull Case $176.15 (+32%)

Analyst growth 17.2%, PE expands to 34.4

Base Case $160.14 (+20%)

Market implied 17.2%, PE stable at 31.3

Bear Case $92.94 (-30%)

Severe decline -20.0%, PE contracts to 26.6

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 26.0 to 26.6

Stabilization Target: $136.19 (+2.2%)

PE Expansion Potential: +2.2%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: July 13, 2026 7:09 PM ET
Data refreshes hourly during market hours. Next update: 8:09 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is ECG showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for ECG.

Create Free Account

Already have an account? Log In

Top Rated Engineering & Construction Stocks

Top-rated stocks in Engineering & Construction by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
PWR Quanta Services Inc	STRONG BUY 30 analysts	$761	59 HOLD
MTZ MasTec Inc	STRONG BUY 17 analysts	$480	53 HOLD
J Jacobs Solutions Inc.	BUY 17 analysts	$157	60 HOLD
ACM Aecom Technology Corpora…	STRONG BUY 13 analysts	$101	57 HOLD
STN Stantec Inc	STRONG BUY 11 analysts	$94	58 HOLD

PWR Quanta Services I…

ACM Aecom Technology …

57 HOLD

STN Stantec Inc

58 HOLD

Advanced ECG Option Strategies

Professional options setups generated by AI based on today's ECG price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ECG

ECG Technical Chart ECG Price Prediction ECG Earnings Date ECG Investment Advisor ECG Fair Price Analyzer ECG Options Advisor ECG Options Chain ECG Options Analysis ECG Competitors

Compare ECG with Peers

ECG vs KNF
Which one to buy?

ECG vs LGN
Which one to buy?

ECG vs BTSG
Which one to buy?

ECG vs PRIM
Which one to buy?

ECG vs MYRG
Which one to buy?

GRBK vs ECG

ECG vs BTSG
Winner: Tie

Create New Comparison View All Competitors

Tradestie